Skip to content

Imaging Response to Immunotherapy and Radiation Therapy in Patients With Liver Metastases

Imaging Response to Immunotherapy and Radiation Therapy in Patients With Liver Metastases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03401814
Enrollment
1
Registered
2018-01-17
Start date
2018-08-02
Completion date
2019-12-12
Last updated
2021-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Metastases

Brief summary

Patients will be imaged with MRE at the time of the RT planning MRI, prior to the induction of RT and immunotherapy. Research imaging will be in addition to standard imaging studies performed at time points consistent with the standard of care (at the time of the RT planning MRI and the first clinical follow-up). An additional MRE exam will be performed at the end of treatment outside the standard of care imaging.

Interventions

rapidly developing technology for quantitatively assessing the mechanical properties of tissue, using externally applied mechanical waves

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Age ≥ 18 years * Diagnosis of solid cancers with the presence of one or more liver metastases * Minimum metastasis diameter ≥ 2 cm * Planning to receive radiation therapy with immunotherapy * Willingness to participate in mandatory imaging studies at Mayo Clinic Rochester

Exclusion criteria

* Contraindications for MRI including claustrophobia, pace maker, metal implants, aneurism clips * Patients who are not able to consent

Design outcomes

Primary

MeasureTime frame
Quantify tissue mechanical properties of the liver and liver tumor using MRE in patients receiving radiation therapy + immunotherapy at baseline, mid-treatment and time of followup imaging determined by standard of care to assess response to therapy1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026